Koers Perrigo Company plc TEL AVIV STOCK EXCHANGE
Aandelen
PRGO
IE00BGH1M568
Farmaceutische producten
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- ILa | -.--% | -2,55% | -3,73% |
07/05 | Perrigo's aangepaste winst over Q1, netto-omzet daalt | MT |
07/05 | Transcript : Perrigo Company plc, Q1 2024 Earnings Call, May 07, 2024 |
Omzet 2024 * | 4,62 mld. 1.693 mld. 4,26 mld. | Omzet 2025 * | 4,83 mld. 1.769 mld. 4,45 mld. | Marktkapitalisatie | 4,05 mld. 1.483 mld. 3,73 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -74 mln. -27,09 mld. -68,17 mln. | Nettowinst (verlies) 2025 * | 106 mln. 38,81 mld. 97,64 mln. | EV/omzet 2024 * | 1,57 x |
Nettoschuld 2024 * | 3,21 mld. 1.175 mld. 2,96 mld. | Nettoschuld 2025 * | 3,01 mld. 1.103 mld. 2,77 mld. | EV/omzet 2025 * | 1,46 x |
K/w-verhouding 2024 * |
-20,5
x | K/w-verhouding 2025 * |
186
x | Werknemers | - |
Dividendrendement 2024 * |
3,71% | Dividendrendement 2025 * |
3,95% | Vrij verhandelbaar | 99,66% |
Recentste transcriptie over Perrigo Company plc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 55 | 30-06-23 | |
Eduardo Bezerra
DFI | Director of Finance/CFO | 49 | 16-05-22 |
Alison Ives
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Orlando Ashford
CHM | Chairman | 55 | 15-12-20 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 06-02-17 |
Bradley Alford
BRD | Director/Board Member | 67 | 06-02-17 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,78% | 723 mld. | |
+31,18% | 598 mld. | |
-3,51% | 364 mld. | |
+19,94% | 331 mld. | |
+5,14% | 288 mld. | |
+16,28% | 244 mld. | |
-4,46% | 208 mld. | |
+9,89% | 210 mld. | |
+9,32% | 169 mld. |
- Beurs
- Aandelen
- Koers PRGO
- Koers PRGO